Abstract:Artificial intelligence is gradually demonstrating its immense potential, and increasing attention is being given to how AI can be harnessed to advance scientific research. In this vision paper, we present our perspectives on how AI can better assist scientific inquiry and explore corresponding technical approach. We have proposed and open-sourced a large model of our KALE-LM model series, Llama3-KALE-LM-Chem-8B, which has achieved outstanding performance in tasks related to the field of chemistry. We hope that our work serves as a strong starting point, helping to realize more intelligent AI and promoting the advancement of human science and technology, as well as societal development.
Abstract:To reduce the experimental validation workload for chemical researchers and accelerate the design and optimization of high-energy-density lithium metal batteries, we aim to leverage models to automatically predict Coulombic Efficiency (CE) based on the composition of liquid electrolytes. There are mainly two representative paradigms in existing methods: machine learning and deep learning. However, the former requires intelligent input feature selection and reliable computational methods, leading to error propagation from feature estimation to model prediction, while the latter (e.g. MultiModal-MoLFormer) faces challenges of poor predictive performance and overfitting due to limited diversity in augmented data. To tackle these issues, we propose a novel method COEFF (COlumbic EFficiency prediction via Fine-tuned models), which consists of two stages: pre-training a chemical general model and fine-tuning on downstream domain data. Firstly, we adopt the publicly available MoLFormer model to obtain feature vectors for each solvent and salt in the electrolyte. Then, we perform a weighted average of embeddings for each token across all molecules, with weights determined by the respective electrolyte component ratios. Finally, we input the obtained electrolyte features into a Multi-layer Perceptron or Kolmogorov-Arnold Network to predict CE. Experimental results on a real-world dataset demonstrate that our method achieves SOTA for predicting CE compared to all baselines. Data and code used in this work will be made publicly available after the paper is published.
Abstract:To enhance therapeutic outcomes from a pharmacological perspective, we propose MiranDa, designed for medication recommendation, which is the first actionable model capable of providing the estimated length of stay in hospitals (ELOS) as counterfactual outcomes that guide clinical practice and model training. In detail, MiranDa emulates the educational trajectory of doctors through two gradient-scaling phases shifted by ELOS: an Evidence-based Training Phase that utilizes supervised learning and a Therapeutic Optimization Phase grounds in reinforcement learning within the gradient space, explores optimal medications by perturbations from ELOS. Evaluation of the Medical Information Mart for Intensive Care III dataset and IV dataset, showcased the superior results of our model across five metrics, particularly in reducing the ELOS. Surprisingly, our model provides structural attributes of medication combinations proved in hyperbolic space and advocated "procedure-specific" medication combinations. These findings posit that MiranDa enhanced medication efficacy. Notably, our paradigm can be applied to nearly all medical tasks and those with information to evaluate predicted outcomes. The source code of the MiranDa model is available at https://github.com/azusakou/MiranDa.